Typically, inflamed or ‘hot’ tumors show an abundance of tumor-infiltrating lymphocytes (TILs), IFNγ-producing CD8+ T cells and high expression of the inhibitory immune checkpoint programmed death-ligand 1 (PD-L1) suggesting a pre-existing antitumor immune response. This evidence concerns the gene CD8A and neoplasm.